CLOSE ×

Use our advanced search tool to find the exact model you need.

Model Search  
B0071 landing page image

FENS Forum 2022

Meet our team in Paris, France in booth #72 from July 10-13 to explore how our expanded portfolio of research models and services can support your neuroscience research.

Learn more  
Group of business people

Career opportunities at Envigo

If you would like to become part of the team that shapes our future, then visit our careers portal for our current vacancies.

Careers Portal  
product-guide-homepage-sub-web-feature

Envigo’s 2022 product guide

Let us help you achieve your unique research goals. Access our latest product guide to explore our expanded research models and services.

Download today  

Latest events

Latest news

Scientific insights

European Association for Cancer Research 2022
June 20-23, 2022 Envigo to exhibit at the 28th Congress of the European Association for Cancer Research EACR 2022 is a four day congress dedicated to basic, preclinical...
FENS 2022
July 9-13, 2022 Founded in 1998 at the first Forum of European Neuroscience, the Federation of European Neuroscience Societies (FENS) is the main organization...
ICT (IUTOX/EUROTOX) 2022
September 18-21, 2022 The Dutch Society of Toxicology (NVT) will host the XVI International Congress of Toxicology in Maastricht, the Netherlands, in Se...
All latest events  
Inotiv, Inc. completes purchase of Envigo
Creates a full-spectrum discovery-to-approval solution for drug developers WEST LAFAYETTE, Ind. and INDIANAPOLIS, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Ino...
Envigo announces collaboration with Biocytogen to distribute the B-NDG triple immunodeficient and humanizable mouse mode
Indianapolis, Indiana, USA, September 28th, 2021 — Envigo RMS Holding Corp. (or Envigo) announces a collaboration with
Inotiv, Inc. and Envigo propose to join forces to enhance research and drug discovery solutions
WEST LAFAYETTE, Ind. and INDIANAPOLIS, Ind.; Sept. 21, 2021 (GLOBE NEWSWIRE) — Inotiv, Inc. (NASDAQ:NOTV) (or “Inotiv”), a leading contrac...
All latest news  
White paper

The Negative Impacts of Pinworms in Laboratory Animal Research

Pinworms are an insidious and common threat to research utilizing laboratory mice and rats. This pest can adversely affect the reproducibility and reliability of research findings. Moreover, the parasitic load and adverse effects caused by pinworms can be even more pronounced in immunodeficient animals.

Case study

Cannulock™ Buttons Extend Catheter Patency in Rodents

Looking to enhance the 3Rs and increase catheter patency at the same time? Cannulock™ Buttons can help. This innovative closed system improves animal and technician welfare while increasing catheter patency.

White paper

PDX, CDX and Allograft Growth in the R2G2® Mouse

Three recent studies made it clear: the R2G2® mouse is well suited for preclinical cancer studies that generate PDX, CDX and allograft models. The R2G2® mouse exhibited reduced radiosensitivity compared to NSGTM mice and tolerated estrogen supplementation and three standard-of-care chemotherapy drugs reasonably well. Moreover, as compared to other traditionally used immunodeficient strains, the R2G2® mouse had higher take rates and more favorable tumor growth.

All Scientific Insights  

No video selected

Select a video type in the sidebar.